The development of a malignant neoplasm of the lung, including distant metastasis and second primary cancer, is an important factor that limits the survival of patients with head and neck squamous cell carcinoma (HNSCC). The most common site of distant metastasis is the lungs,
1,2 with an incidence of 8% to 15% in clinical studies.
1-3 Primary lung cancers account for 23% of second primary tumors in patients with HNSCC.
4 Because the presence of a malignant neoplasm of the lung may alter the case management, evaluation of the chest condition is important for patients with HNSCC at the initial diagnosis and during the follow-up period.